Atlas Trials

A Phase II Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula

Clinical trial NCT03174353 · COMPLETED

Trial details

NCT number
NCT03174353
Sponsor
University of Washington
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic LeakPancreatic FistulaPancreaticoduodenal; FistulaPancreatectomy; Hyperglycemia
Start date
2018-02-20
Primary completion
2021-02-01
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.